{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:01:43Z","timestamp":1773903703879,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1987,10,1]],"date-time":"1987-10-01T00:00:00Z","timestamp":560044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1987,10,1]],"date-time":"1987-10-01T00:00:00Z","timestamp":560044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1987,10]]},"DOI":"10.1136\/ard.46.10.757","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"757-762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease."],"prefix":"10.1016","volume":"46","author":[{"given":"K","family":"Berglund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Thysell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"1062","article-title":"Treatment of renal amyloidosis lEditoriall","volume":"i:","author":"Anonymous","year":"1980","unstructured":"Anonymous. Treatment of renal amyloidosis lEditoriall. Lancet 1980; i: 1062-3.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM198006123022403","article-title":"Amyloid deposits and amyloidosis","volume":"302","author":"G, Glenner G.","year":"1980","unstructured":"Glenner G G. Amyloid deposits and amyloidosis. N EnglJ Med 1980; 302: 1333-43.","journal-title":"N EnglJ Med"},{"key":"ref_3","first-page":"381","article-title":"Amyloidosis: a familiar problem in the light of current pathogenetic developments","volume":"49","author":"Kisilevsky, R.","year":"1983","unstructured":"Kisilevsky R. Amyloidosis: a familiar problem in the light of current pathogenetic developments. Lab Invest 1983; 49: 381-90.","journal-title":"Lab Invest"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00005792-198111000-00004","article-title":"Clinical-pathologic diffcrentiation of common amyloid syndromes","volume":"60","author":"R, Wright J.; E, Calkins","year":"1981","unstructured":"Wright J R, Calkins E. Clinical-pathologic diffcrentiation of common amyloid syndromes. Medicine (Baltitnore) 1981; 60: 429-48.","journal-title":"Medicine (Baltitnore)"},{"key":"ref_5","first-page":"183","article-title":"Follow-up study of amyloidosis secondary to rheumatic disease","author":"G, Glenner G.","year":"1980","unstructured":"Wegelius 0, Wafin F, Falck H, Tornroth T. Follow-up study of amyloidosis secondary to rheumatic disease. In: Glenner G G, Costa P P, de Freitas F, eds. Amyloid and amyloidosis. Amsterdam: Excerpta Medica, 1980: 183-90."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0002-9343(77)90281-9","article-title":"Resolution of renal amyloidosis","volume":"63","author":"H, Dikman S.; T, Kahn; D, Gribetz; J, Churg","year":"1977","unstructured":"Dikman S H, Kahn T, Gribetz D, Churg J. Resolution of renal amyloidosis. Am J Med 1977; 63: 430-3.","journal-title":"Am J Med"},{"key":"ref_7","first-page":"245","article-title":"Amyloidosis in juvenile chronic polyarthritis","volume":"(suppl):","author":"J, Schnitzer T.; M, Ansell B.","year":"1977","unstructured":"Schnitzer T J, Ansell B M. Amyloidosis in juvenile chronic polyarthritis. Arthritis Rheum 1977; 20 (suppl): 245-52.","journal-title":"Arthritis Rheum"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.0954-6820.1979.tb06121.x","article-title":"Resolution of renal amyloidosis secondary to rheumatoid arthritis","volume":"205","year":"1979","unstructured":"Falck H M, Tornroth T, Skrifvars B, Wegelius 0. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand 1979; 205: 651-6.","journal-title":"Acta Med Scand"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1475-097X.1981.tb00885.x","article-title":"On the necessity of strict bed rest during determination of 5'Cr-EDTA clcarance","volume":"1","author":"Brauner, L.; Westling, H.","year":"1981","unstructured":"Brauner L, Westling H. On the necessity of strict bed rest during determination of 5'Cr-EDTA clcarance. Clin Physiol 1981; 1: 175-80.","journal-title":"Clin Physiol"},{"key":"ref_10","first-page":"7","article-title":"Nived 0, Sjoholm A G, Sturfelt G. Complement activation, circulating Clq binding substances and inflammatory activity in rheumatoid arthritis","volume":"4","author":"Berglund, K.; Laurell, A.-B.","year":"1980","unstructured":"Berglund K, Laurell A-B, Nived 0, Sjoholm A G, Sturfelt G. Complement activation, circulating Clq binding substances and inflammatory activity in rheumatoid arthritis. J Clin Lab Immunol 1980; 4: 7-14.","journal-title":"J Clin Lab Immunol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9343(85)90243-8","article-title":"Review of United States data on neoplasms in rheumatoid arthritis","volume":"78","author":"W, Castor C.; E, Bull F.","year":"1985","unstructured":"Castor C W, Bull F E. Review of United States data on neoplasms in rheumatoid arthritis. Am J Med 1985; 78 (suppl IA): 33-8.","journal-title":"Am J Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0002-9343(85)90244-X","article-title":"Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens","volume":"78","author":"Hazleman, B.","year":"1985","unstructured":"Hazleman B. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. Ain J Med 1985; 78 (suppl IA): 39-43.","journal-title":"Ain J Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"78","author":"J, Kinlen L.","year":"1985","unstructured":"Kinlen L J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78 (suppl IA): 44-9.","journal-title":"Am J Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198512263132601","article-title":"Effect of captopril on heavy proteinuria in azotemic diabetics","volume":"313","author":"Taguma, Y.; Kitamoto, Y.; Futaki, G.","year":"1985","unstructured":"Taguma Y, Kitamoto Y, Futaki G. et al. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617-20.","journal-title":"N Engl J Med"},{"key":"ref_15","first-page":"3389","article-title":"Dramatic aggravation of renal amyloidosis after surgery","volume":"10","author":"Jacquot, C.; d'Auzac, C.; Loirat, P.; Bariety, J.","year":"1981","unstructured":"Jacquot C, d'Auzac C, Loirat P, Bariety J. Dramatic aggravation of renal amyloidosis after surgery. Presse Med 1981; 10: 3389-95.","journal-title":"Presse Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/00365527709181699","article-title":"Amyloidosis and Crohn's disease","volume":"12","author":"Fausa 0, Nygaard K, Elgjo K","year":"1977","unstructured":"Fausa 0, Nygaard K, Elgjo K. Amyloidosis and Crohn's disease. Scand J Gastroenterol 1977; 12: 657-62.","journal-title":"Scand J Gastroenterol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"M, Clive D.; S, Stoff J.","year":"1984","unstructured":"Clive D M, Stoff J S. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310: 563-72.","journal-title":"N Engl J Med"},{"key":"ref_18","first-page":"65","article-title":"Serum amyloid protein A concentrations in patients with RA and amyloidosis-effect of treatment with cytostatic drugs lAbstract]","volume":"59","author":"Husebekk, A.; Ahlmen, M.; Husby, G.","year":"1986","unstructured":"Husebekk A, Ahlmen M, Husby G. Serum amyloid protein A concentrations in patients with RA and amyloidosis-effect of treatment with cytostatic drugs lAbstract]. Scand J Rheumatol ISuppli 1986; 59: 65.","journal-title":"Scand J Rheumatol ISuppli"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724123837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724123837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.46.10.757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:16:26Z","timestamp":1738304186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724123837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1987,10]]}},"alternative-id":["S0003496724123837"],"URL":"https:\/\/doi.org\/10.1136\/ard.46.10.757","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1987,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.46.10.757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1987 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}